George Clinical has expertise in disorders that affect the brain, such as stroke, epilepsy, dementia, and sleep apnea. George Clinical’s neurological investigator networks have been cultivated over many years by participating in some of the world’s largest clinical neurology research trials, one of which is the largest ever acute ischemic stroke trial.
Stroke is a second leading cause of death worldwide and expected to worsen as society ages. In Asia, the change in lifestyle and diet has seen a marked increase in the prevalence of stroke, particularly in ischaemic stroke.
George Clinical has supported the work of The George Institute for Global Health to reduce the worldwide burden of neurological diseases by implementing a number of high impact clinical trials and establishing a network of over 200 sites and recruiting over 10,000 patients from around the world. The George Clinical neurological investigator network is particularly strong in the Asia Pacific, with centers deep within North Asia where ischemic stroke is most prevalent.
George Clinical engages with scientific leaders that are regularly called upon to develop new strategies for global decision makers on how neurological medicine is practiced.
George Clinical’s therapeutic expertise spread throughout 27 countries and 162 sites.
Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia. He is Executive Director of The George Institute, China and based with the team at Peking University Health Science Center in Beijing, China.
Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia. He is a past President of the Asia Pacific Stroke Organization and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group. He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.
Candice Delcourt is a neurologist specializing in stroke medicine. She is a Senior Research Fellow at The George Institute in Sydney and the Hunter Stroke Service in Newcastle. She is a Senior Clinical Lecturer at the University of Sydney. She holds a clinical appointment at the Royal Prince Alfred Hospital.
She obtained her specialist medical qualification in Neurology from the University of Liege (Belgium) and additional qualifications in cerebro-vascular medicine from the University of Dijon (France) and in neurophysiology from the University of Lille (France).
She is an executive committee member of the Stroke Society of Australasia and the Australian Stroke Trial Network.